Literature DB >> 35236955

Darolutamide combo is an ARASENSible option for mHSPC.

Annette Fenner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35236955     DOI: 10.1038/s41585-022-00579-0

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Darolutamide in Metastatic Prostate Cancer. Reply.

Authors:  Matthew R Smith
Journal:  N Engl J Med       Date:  2022-06-16       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.